The recommended dose escalation schedule is: Weeks 1 to 4: 0.8mg once daily (starting dose) Weeks 5 to 8: 2.5mg once daily Weeks 9 to 12: 5.5mg once daily Week 13 onwards: the dose may be further increased to 9mg, 14.5mg or 17.2mg once daily, depending on individual response and tolerability If a dose is missed, it should be taken as soon as possible on the same day
Strictly for scientific and laboratory use
And weight gain is often driven by multiple factors: hormones, insulin resistance, medications, sleep deprivation, stress, and muscle loss
This can: In many ways, GLP-1 therapy is genuinely good for people with vein disease
Glucagon-like Peptide-1 (GLP-1) Agonists Market Trends Steady Growth : The global GLP-1 Receptor Agonist Market is set to witness steady growth, forecast to be a $100 Billion market by 2030
& Habener, J